Elekta AB (publ) (OTCMKTS:EKTAY) Hits New 1-Year Low – Time to Sell?

Elekta AB (publ) (OTCMKTS:EKTAY) shares hit a new 52-week low during trading on Tuesday . The company traded as low as $5.25 and last traded at $5.25, with a volume of 2333 shares traded. The stock had previously closed at $5.46.

Elekta AB (publ) Price Performance

The company has a current ratio of 0.99, a quick ratio of 0.74 and a debt-to-equity ratio of 0.45. The company has a market cap of $2.01 billion, a PE ratio of 21.00 and a beta of 1.23. The firm has a 50 day moving average of $5.89 and a two-hundred day moving average of $6.23.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.